Butalbital, Aspirin, Cafeine, and Codeine Phosphate

CHEBI:CHEBI_747102

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class
Decreased Platelet Aggregation [PE]
dea_schedule
CIII
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Xanthines [CS]
pharm_class_pe
Decreased Prostaglandin Production [PE]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
ASPIRIN
rxcui
994239
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
route
ORAL
marketing_category
ANDA
active_ingredient_strength
30 mg/1
dosage_form
CAPSULE
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
unii
R16CO5Y76E
labeler_name
Breckenridge Pharmaceutical, Inc.
manufacturer_name
Breckenridge Pharmaceutical, Inc.
package_marketing_start_date
20140926
generic_name
Butalbital, Aspirin, Caffeine and Codeine Phosphate
brand_name
BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE
brand_name_base
BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE
product_ndc
51991-074
application_number
ANDA074951
marketing_start_date
19980831
spl_id
d454ba0a-b236-4529-ad63-4b995fbc3e32
package_ndc
51991-074-05
package_description
500 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-05)
spl_set_id
243a6aea-0f48-42a9-a85e-ff247ab94336
upc
0351991074014